152 related articles for article (PubMed ID: 35925120)
1. [Dyspnea and edema in a 79-year old male].
Schwarz F; Klingel K; Greulich S; Gawaz M
Inn Med (Heidelb); 2022 Sep; 63(9):994-999. PubMed ID: 35925120
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterisation of amyloid by endomyocardial biopsy.
Benson MD; Breall J; Cummings OW; Liepnieks JJ
Amyloid; 2009 Mar; 16(1):9-14. PubMed ID: 19291509
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.
Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y
Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908
[TBL] [Abstract][Full Text] [Related]
4. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
5. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.
Siddiqi OK; Ruberg FL
Trends Cardiovasc Med; 2018 Jan; 28(1):10-21. PubMed ID: 28739313
[TBL] [Abstract][Full Text] [Related]
7. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.
Molina O G; Judge D; Campbell W; Chahal H; Mugmon M
J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
[TBL] [Abstract][Full Text] [Related]
9. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
10. [The rapid progress of heart failure due to systemic amyloidosis with cardiac involvement--case report].
Gilowski W; Stryjewski P; Gilowska M; Liszniański P; Nowak J
Przegl Lek; 2015; 72(11):697-700. PubMed ID: 27012134
[TBL] [Abstract][Full Text] [Related]
11. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
Hesse A; Altland K; Linke RP; Almeida MR; Saraiva MJ; Steinmetz A; Maisch B
Br Heart J; 1993 Aug; 70(2):111-5. PubMed ID: 8038017
[TBL] [Abstract][Full Text] [Related]
12. Case report: isolated cardiac amyloidosis: an enigma unravelled.
Khalid U; Awar O; Verstovsek G; Cheong B; Yellapragada SV; Jneid H; Deswal A; Virani SS
Methodist Debakey Cardiovasc J; 2015; 11(1):53-8. PubMed ID: 25793032
[TBL] [Abstract][Full Text] [Related]
13. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
Thenappan T; Fedson S; Rich J; Murks C; Husain A; Pogoriler J; Anderson AS
Amyloid; 2014 Jun; 21(2):120-3. PubMed ID: 24818650
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostics of cardiac amyloidosis].
Meier C; Yilmaz A
Inn Med (Heidelb); 2023 Sep; 64(9):830-841. PubMed ID: 37553542
[TBL] [Abstract][Full Text] [Related]
15. Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis.
Makivic N; Stöllberger C; Nakuz T; Schneider B; Schmid C; Hasun M; Weidinger F
ESC Heart Fail; 2020 Aug; 7(4):1987-1991. PubMed ID: 32515557
[TBL] [Abstract][Full Text] [Related]
16. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant.
Ikura H; Kitakata H; Endo J; Moriyama H; Sano M; Tsujikawa H; Sawano M; Masuda T; Ohki T; Ueda M; Kosaki K; Fukuda K
Eur J Med Genet; 2022 Mar; 65(3):104451. PubMed ID: 35149236
[TBL] [Abstract][Full Text] [Related]
17. Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy.
Murat S; Çavuşoğlu Y; Ak Sivrikoz İ
Turk Kardiyol Dern Ars; 2021 Oct; 49(7):579-584. PubMed ID: 34623301
[TBL] [Abstract][Full Text] [Related]
18. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
[TBL] [Abstract][Full Text] [Related]
19. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
Manolis AS; Manolis AA; Manolis TA; Melita H
Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
